Abstract
A rational choice between medical and surgical therapy in any disease entity can only exist when both forms of therapy are possible. In hypertrophic cardiomyopathy (HCM), there is a choice between medical and surgical therapy in the clinical syndromes listed in Table 1. In this review, we will discuss the various forms of medical and surgical therapy that are available to patients with HCM, but will focus on the Toronto experience, which is based on the hemodynamic classification of this disease [1–6]. We will not discuss those forms of HCM that are only amenable to medical therapy, because in those there is no rational choice between medical and surgical therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wigle ED, Heimbecker RO, Gunton RW (1962) Idiopathic ventricular septal hypertrophy causing muscular subaortic stenosis. Circulation 26: 325–340
Wigle ED, Adelman MD, Felderhof CH (1974) Medical and surgical treatment of the cardiomyopathies. Circ Res 34, 35 II-196–207
Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG (1985) Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 28: 1–83
Wigle ED (1987) Hypertrophic cardiomyopathy. A 1987 viewpoint. (Editorial) Circulation 75: 311–322
Wigle ED, Rakowski H (1987) Evidence for true obstruction to left ventricular outflow in obstructive hypertrophic cardiomyopathy (muscular of hypertrophic subaortic stenosis). Z Kardiol 76: 61–68
Wigle ED (1988) Hypertrophic cardiomyopathy 1988. Mod Concepts Cardiovasc Dis 57: 1–6
Murgo JP, Alter BR, Dorethy JF, Altobelli SA, McGranahan GM Jr (1980) Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy. J Clin Invest 66: 1369–1382
Falicov RE,Resnekov L, Bharati S et al (1976) Midventricular obstruction: a variant of obstructive cardiomyopathy. Am J Cardiol 37: 432–437
Criley MJ, Lewis KB, White RI, Ross RS (1965) Pressure gradients without obstruction: a new concept of “hypertrophic subaortic stenosis”. Circulation 22: 881–887
Grose RM, Strain JE, Spindola-Franco H (1986) Angiographic and hemodynamic correlations in hypertrophic cardiomyopathy. Am J Cardiol 58: 1085–1092
Wigle ED, Auger P, Marquis Y (1966) Muscular subaortic stenosis: the initial left ventricular inflow tract pressure as evidence of outflow tract obstruction. Can Med Assoc J 95: 793–797
Wigle ED, Marquis Y, Auger P (1967) Muscular subaortic stenosis: Initial left ventricular inflow tract pressure in the assessment of intraventricular pressure differences in man. Circulation 35: 1100–1117
Criley MJ, Seigel RJ (1985) Has ‘obstruction’ hindered our understanding of hypertrophic cardiomyopathy? Circulation 72: 1148–1154
Wigle ED, Adelman AG, Silver MD (1971) Pathophysiological considerations in muscular subaortic stenosis. In: Wolstenholme GEW, O’Connor M (eds) Hypertrophic obstructive cardiomyopathy. Ciba Foundation Study Group 47. Ciba Foundation, London, pp 63–76
Gilbert BW, Pollick C, Adelman AG, Wigle ED (1980) Hypertrophic cardiomyopathy: subclassification by M-mode echocardiography. Am J Cardiol 45: 861
Pollick C, Gilbert BW, Rakowski H, Morgan CD, Wigle ED (1982) Muscular subaortic stenosis: the temporal relationship between systolic anterior motion of the anterior mitral leaflet and the pressure gradient. Circulation 66: 1087–1093
Pollick C, Rakowski H, Wigle ED (1984) Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient. Circulation 69-1: 43–49
Glasgow GA, Gardin JM, Burns CS, Childs WJ, Henry WL (1980) Echocardiographic and Doppler flow observations in idiopathic hypertrophic subaortic stenosis (IHSS) Circulation 62:III-99 (abstr)
Bonow RO, Ostrow HG, Rosing DR, Cannon RO, Leon MB, Watson RM, Bacharach SL, Green MV, Epstein SE (1984) Dynamic pressure-volume alterations during left ventricular ejection in hypertrophic cardiomyopathy: evidence for true obstruction to left ventricular outflow. Circulation 70: 11–17 (abstr)
Hatle L, Angelsen B (1985) (eds) Doppler ultrasound in cardiology. Lea and Febiger, Philadelphia, pp 205–217
Bonow RO, Crawford-Green C, Betocci S, Rosing DR, Maron BJ (1985) Left ventricular ejection dynamics in hypertrophic cardiomyopathy: comparison with valvular aortic stenosis. J Am Coll Cardiol 5: 395 (abstr)
Pouleur H Van Eyll C, Gurne O, Hanet C, Rousseau MF (1985) Regional velocity of shortening in hypertrophic cardiomyopathy: evidence for true impedance to shortening in the presence of outflow gradients. Circulation 72: 111–448 (abstr)
Rakowski H, Sasson Z, Wigle ED (1988) Echocardiographic and Doppler assessment of hypertrophic cardiomyopathy. J Am Soc Echo 1: 31–47
Stewart WJ, Schiavone WA, Salcedo EE, Lever HM, Cosgrove DM, Grill CC (1985) Intraoperative Doppler velocity correlates with outflow gradient in HOCM pre- and postmyectomy. Circulation 72: 111–447 (abstr)
Holt B, Sahn DJ, Dalton N, Smith SC, Yun Y, Dittrich H (1985) Color Doppler flow mapping studies of jet formation in hypertrophic cardiomyopathy (HCM). Circulation 72: 111–447 (abstr)
Sasson Z, Yock PG, Hatle LK, Alderman EL, Popp R (1986) Noninvasive determination of the pressure gradient in hypertrophic cardiomyopathy. Circulation 74: 11–215 (abstr)
Wigle ED, Adelman AG, Auger P, Marquis Y (1969) Mitral regurgitation in muscular subaortic stenosis. Am J Cardiol 24: 698–706
Adelman AG, McLoughlin MJ, Marquis Y, Auger P, Wigle ED (1969) Left ventricular cineangiographic observations in muscular subaortic stenosis. Am J Cardiol 24: 689–697
Ross J Jr, Braunwald E, Gault JH, Mason DT, Morrow AG (1966) The mechanism of the intraventricular pressure gradient in idiopathic hypertrophic subaortic stenosis. Circulation 34: 558–578
Wigle ED, Auger P, Marquis Y (1967) Muscular subaortic stenosis: the direct relation between the intraventricular pressure gradient and left ventricular ejection time. Circulation 36: 36–44
Sasson Z, Henderson M, Wilansky S, Rakowski H, Wigle ED (1989) Causal relation between the pressure gradient and left ventricular ejection time in hypertrophic cardiomyopathy. J Am Coll Cardiol 13: 1275–1279
Maron BJ, Gottdiener JS, Arce J, Rosing DR, Wesley YE, Epstein SE (1985) Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography. J Am Coll Cardiol 6: 1–15
Pierce GE, Morrow AG, Braunwad E (1964) Idiopathic hypertrophic subaortic stenosis III. Intraoperative studies of the mechanism of obstruction and its hemodynamic consequences. Circulation 30:IV, 152–207
Bircks W, Bostroem B, Gleichmann U, Kruezer H, Loogen F (1968) Electromagnetic flow measurement in the ascending aorta before and after repair of valvular and subvalvular lesions including IHSS. Proceedings of the Vth European Congress of Cardiology (Athens), pp 13–22
Jenni R, Ruffman K, Vieli A, Anlinker M, Krayenbuehl HP (1985) Dynamics of aortic flow in hypertrophic cardiomyopathy. Eur Heart J 6: 391–398
Hernandez RR, Greenfiled JC Jr, McCall BW (1964) Pressure-flow studies in hypertrophic subaortic stenosis. J Clin Invest 43: 401–107
Cannon RO, Rosing DR, Mcintosh CL, Epstein SE (1985) Hypertrophic cardiomyopathy (HCM): improved hemodynamics, metabolism, and anginal threshold following surgical relief of obstruction. Circulation 72:III–447 (abstr)
Frank MJ, Abdulla AM, Watkins O, Prisant L, Stefadouros MA (1983) Long-term medical management of hypertrophic cardiomyopathy: usefulness of propranolol. Eur Heart J 4: 155–164
Kaltenbach M, Hopf R, Kober G, Bussman WD, Keller M, Petersen Y (1979) Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Br Heart J 42: 35–42
Kaltenbach M, Hopf R (1985) Treatment of hypertrophic cardiomyopathy: Relation to pathological mechanisms. J Mol Cell Cardiol 17: 59–68
Rosing DR, Kent KM, Border JS, Seides SF, Maron BJ, Epstein SE (1979) Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy I. Hemodynamic effects. Circulation 60: 1201–1207
Rosing DR, Condit JR, Maron BJ, Kent KM, Leon MB, Bonow RO, Lipson LC, Epstein SE (1981) Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration. Am J Cardiol 48: 545–553
Rosing DR, Idanpaan-Heikkila U, Maron BJ, Bonnow RO, Epstein SE (1985) Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy. Am J Cardiol 55 (Suppl) 185B–195B
Pollick C (1982) Muscular subaortic stenosis. Hemodynamic and clinical improvement after disopyramide. N Eng J Med 307: 997–999
Pollick C, Kimball B, Henderson M, Wigle ED (1988) Disopyramide in hypertrophic cardiomyopathy I. Hemodynamic assessment after intravenous administration. Am J Cardiol 62: 1248–1251
Wigle ED, Chrysohou A, Bigelow W (1963) Results of ventriculomyotomy in muscular subaortic stenosis. Am J Cardiol 11: 572–586
Bigelow WG, Trimble AS, Wigle ED, Adelman AG, Felderhof C (1974) The treatment of muscular subaortic stenosis. Thorac Cardiovasc Surg 68: 384–392
Williams WG, Wigle ED, Rakowski H, Smallhorn J, Le Blanc J, Trusler GA (1987) Results of surgery for idiopathic hypertrophic obstructive cardiomyopathy (IHSS). Circulation 76-II: 104–108
McKenna WJ, England D, Doi YL, Deanfiled JE, Oakley C, Goodwin JF (1981) Arrhythmia in hypertrophic cardiomyopathy I. Influence on prognosis. Br Heart J 46: 168–172
Shah PM, Adelman AG, Wigle ED et al (1975) The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circ Res 34, 35 (Suppl 2): 179–186
Maron BJ, Epstein SE, Morrow AG (1983) Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy and myectomy. Eur Heart J 4 (Suppl F): 175–185
Beahrs MM, Tajak AJ, Seward JB et al (1983) Hypertrophic obstructive cardiomyopathy: 10–21 year follow-up after partial septal myectomy. Am J Cardiol 51: 1160–1166
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Wigle, E.D., Williams, W.G., Kimball, B., Sasson, Z., Rakowski, H. (1990). Rational Choice of Medical and/or Surgical Therapy in Hypertrophic Cardiomyopathy. In: Baroldi, G., Camerini, F., Goodwin, J.F. (eds) Advances in Cardiomyopathies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83760-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-83760-9_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83762-3
Online ISBN: 978-3-642-83760-9
eBook Packages: Springer Book Archive